Search
Search Results
##search.searchResults.foundPlural##
-
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1965PDF: 812HTML: 221 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3299PDF: 1342HTML: 2630 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5149PDF: 1321HTML: 2744Cover letter: 194 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4494PDF: 1922HTML: 17746 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3968PDF: 1300HTML: 2261 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
834PDF: 814HTML: 125 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2181PDF: 1199HTML: 3713 -
-
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2794PDF: 1116HTML: 11216 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6814PDF: 3645HTML: 753 -
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1181PDF: 792HTML: 1771 -
BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI
5275PDF: 2567HTML: 30200Antinori Tables 1,2,3: 347 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
678PDF: 541HTML: 86 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1604PDF: 583HTML: 225 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
695PDF: 530HTML: 212 -
-
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1545PDF: 905HTML: 1954Figure: 170Tables: 185ALL revision 1: 190response to reviewer: 180 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
874PDF: 623HTML: 108 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3885PDF: 1478HTML: 8513 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1356PDF: 469HTML: 168 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
1002PDF: 671Html: 156 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3771PDF: 1484HTML: 485Figures . Eliassian: 222 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1392PDF: 819HTML: 3123 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2129PDF: 1693HTML: 378 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3995PDF: 1052HTML: 3590Untitled: 177Cneo. Fig.1: 114Untitled: 104Untitled: 126Untitled: 132 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3265PDF: 1535HTML: 424 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2556PDF: 964HTML: 15105







